Allogeneic human pancreatic islets of Langerhans (City of Hope Medical Center/University Of California, Los Angeles)

N/A

Report date: 2024/07/18 20:00:08

Base Information

Drug NameAllogeneic human pancreatic islets of Langerhans (City of Hope Medical Center/University Of California, Los Angeles)
Drug Alias NameIslet cell transplantation (City of Hope Medical Center/University Of California, Los Angeles)Allogenic islet transplantation (City of Hope Medical Center/University Of California, Los Angeles)Allogeneic human pancreatic islets of Langerhans (City of Hope Medical Center/University Of California, Los Angeles)
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Pancreatic islet cell therapyCell and gene therapy > Cell therapy > Source of cells > Pancreatic islet-derived
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical CenterUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A